Acute Lymphoblastic Leukemia in Young Adults Treated with Intensive “Pediatric” Type Protocol
- 17 October 2017
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 34 (3) , 422-429
Abstract
Young adults with acute lymphoblastic leukemia do better when treated on “pediatric” protocols. Young adults (18–30 years) with Ph-negative ALL treated between 2000 and 2014 were retrospectively analyzed. Two-hundred and thirty-two patients were included [median age 21 years (18–30); 176 (76%) males; median WBC 16,000/cmm]. Protocols used were: BFM 95 (N = 147, 63%), MCP-841 (N = 51, 22%), GMALL (N = 21, 9%), INCTR (N = 9, 4%) and UKALL (N = 4, 2%). Complete remission was achieved in 194/232 (84%). Twenty patients (9%) died due to toxicity which was higher with BFM versus others (18/147 vs. 2/85; p = 0.031). After a median follow-up of 48 months, median RFS and OS were 35.5 months (25–46), and 25 months (18–31) and actuarial RFS and OS (5-years) were 45% (37–53) and 39% (32–46). BFM protocol improved RFS (51 vs. 35%, p = 0.027) but not OS (43 vs. 33%, p = 0.2). The survival outcomes reported are 15–20% lower than those reported from West. Better supportive care and risk-adapted therapy may improve outcomes.Keywords
This publication has 18 references indexed in Scilit:
- Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003British Journal of Haematology, 2015
- Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocolIndian Journal of Medical and Paediatric Oncology, 2015
- How I treat acute lymphoblastic leukemia in older adolescents and young adultsBlood, 2015
- Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemiaBlood, 2015
- Acute myeloid leukaemia: challenges and real world data from IndiaBritish Journal of Haematology, 2015
- Pattern of Relapse in Childhood ALL: Challenges and Lessons From a Uniform Treatment ProtocolJournal of Pediatric Hematology/Oncology, 2010
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008
- Result of childhood acute lymphoblastic leukemia protocol (INCTR) from a developing countryJournal of Clinical Oncology, 2007
- Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Blood, 2005
- TREATMENT OF ADULT ALL ACCORDING TO PROTOCOLS OF THE GERMAN MULTICENTER STUDY GROUP FOR ADULT ALL (GMALL)Hematology/Oncology Clinics of North America, 2000